# Time Course of Response to Methylphenidate HCl ER Capsules in Children 6 to 12 Years With ADHD in Classroom Setting

> **NCT01269463** · PHASE3 · COMPLETED · sponsor: **Rhodes Pharmaceuticals, L.P.** · enrollment: 26 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder
- ADHD

## Interventions

- **DRUG:** Methylphenidate Hydrochloride Extended Release Capsule
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01269463
- **Lead sponsor:** Rhodes Pharmaceuticals, L.P.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01-19
- **Primary completion:** 2011-06-18
- **Final completion:** 2013-03-13
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2022-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01269463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01269463, "Time Course of Response to Methylphenidate HCl ER Capsules in Children 6 to 12 Years With ADHD in Classroom Setting". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01269463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*